ContraceptionReturn to fertility after cessation of a continuous oral contraceptive
Under an Elsevier user license
open archive
Key Words
Return to fertility
oral contraceptive
low-dose
continuous
noncyclic
Cited by (0)
Supported by a grant from Wyeth Research, Collegeville, Pa.
K.B. was an investigator for this poststudy follow-up and received research funding from Wyeth Research, Collegeville, Pa. Other sources of research funding and/or financial relationships include Novo Nordisk (consultant), Organon (speaker and investigator), Johnson & Johnson, Duramed, Xanodyne, Boehringer Ingelheim, Third Wave, Pfizer, and MGI Pharma (investigator). S.M., G.G., and G.C. are employees of Wyeth Research. Other financial affiliation for G.G. is Johnson & Johnson. S.M. and G.C. have no other financial affiliation to disclose.
Copyright © 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.